FMC (FMC) AI Stock Analysis

• Market Cap: $5.55B
• Dividend Yield: 5.22%
• Average Volume (3M): 1.86M
• Price to Earnings (P/E): 17.1
• Beta (1Y): 0.85
• Revenue Growth: 1.45%
• EPS Growth: -70.85%
• Country: US
• Employees: 5,700
• Sector: Basic Materials
• Sector Strength: 73
• Industry: Agricultural Inputs
• EPS (TTM): 0.18
• Shares Outstanding: 124,909,225
• 10 Day Avg. Volume: 1,726,845
• 30 Day Avg. Volume: 1,862,839
• PEG Ratio: -4.27
• Price to Book (P/B): 1.17
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 25.86
• Enterprise Value/Market Cap: 1.59
• Enterprise Value/Revenue: 0.53
• Enterprise Value/Gross Profit: 5.45
• Enterprise Value/Ebitda: 3.78
• 1Y Price Target: $46.00
• Price Target Upside: 3.49% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 12

• Rating: 69 Neutral
• Price Target: $47.00 ▲(5.74%Upside)

FMC's overall score is 69, reflecting a moderate outlook with potential for recovery. Financial performance is challenged by declining revenue and cash flow issues, but the balance sheet is stable. Technical analysis indicates positive momentum, while valuation and earnings call insights suggest strategic opportunities for growth in the latter half of 2025.

Positive Factors

Earnings

FMC posted a 1Q25 earnings beat driven by better than expected revenue from Latin America.

Market Expansion

The new Brazilian sales channel could expand the addressable market by ~30% by targeting large farms focused on corn and soy.

Product Portfolio

Cyazypyr should remain a tailwind through 2028-2029, with growth rates of 13-17%, and new products are expected to add $800m-$1bn by 2030.

Negative Factors

Competition

The company is seeing increased generic competition for Rynaxypyr in China, India, Eastern Europe and South America, pressuring both pricing and volumes.

Financial Performance

Lower EBITDA and FCF mean less support for FMC stock until free cash flow improves.

Trade Policy

A headwind from US tariffs on Canadian imports is expected to impact FMC's sales and earnings, with each 1% hit to US farm profits potentially cutting FMC sales by $3.8-5.8m.

FMC Business Overview & Revenue Model

Company Description

FMC Corporation (FMC) is a global agricultural sciences company that provides innovative solutions to growers worldwide. The company operates primarily in the agricultural sector, offering a diverse portfolio of crop protection products, including insecticides, herbicides, and fungicides. FMC is committed to advancing sustainable agriculture through its research and development efforts, delivering technologies that enhance crop yield and quality while minimizing environmental impact.

How the Company Makes Money

FMC Corporation generates revenue primarily through the sale of its crop protection products. These products are sold to distributors and directly to farmers, helping protect crops from pests, weeds, and diseases. The company's revenue streams are diversified across various geographic regions, allowing it to capitalize on agricultural cycles and market demands globally. FMC also invests in research and development to innovate and introduce new products, which can command premium pricing. Strategic partnerships and collaborations with other agricultural and chemical companies further enhance its product offerings and market reach, contributing to its earnings.

FMC Financial Statement Overview

Summary

FMC shows moderate financial health with a stable balance sheet and manageable debt level. However, revenue and profit margins have declined, indicating potential headwinds in growth and operational efficiency. The most significant concern is the substantial decline in free cash flow, pointing to potential liquidity issues.

Income Statement

The TTM revenue of $4.12 billion shows a decline from the previous year's $4.49 billion, indicating a negative revenue growth rate. The gross profit margin is approximately 39.3%, showing strong profitability but with a slight decline from previous periods. The net profit margin stands at 8.1%, showing moderate profitability. However, EBIT and EBITDA margins have decreased, suggesting potential challenges in operational efficiency.

Balance Sheet

The debt-to-equity ratio is moderate at 0.22, indicating a balanced approach to leverage. The return on equity (ROE) is approximately 7.6%, which is relatively low, suggesting room for improvement in generating returns for shareholders. The equity ratio is around 37.1%, showing a stable capital structure with a healthy equity base.

Cash Flow

The free cash flow has decreased significantly from $603.2 million to $243.3 million, indicating a substantial negative growth rate. The operating cash flow to net income ratio is 0.87, which is below optimal levels, suggesting challenges in cash generation relative to net income. The free cash flow to net income ratio is 0.73, showing limited free cash flow generation.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	4.12B	4.25B	4.49B	5.80B	5.05B	4.64B
Gross Profit	1.62B	1.65B	1.83B	2.33B	2.17B	2.05B
EBITDA	657.40M	737.40M	786.20M	1.30B	1.19B	1.04B
Net Income	327.60M	339.90M	1.32B	736.50M	739.60M	552.40M
Balance Sheet
Total Assets	11.80B	11.65B	11.93B	11.17B	10.58B	10.19B
Cash, Cash Equivalents and Short-Term Investments	315.30M	357.30M	302.40M	572.00M	516.80M	568.90M
Total Debt	4.00B	3.50B	4.11B	3.27B	3.17B	3.27B
Total Liabilities	7.39B	7.14B	7.49B	7.77B	7.53B	7.20B
Stockholders Equity	4.38B	4.49B	4.41B	3.40B	3.05B	2.98B
Cash Flow
Free Cash Flow	198.40M	603.20M	-520.30M	440.10M	720.00M	580.60M
Operating Cash Flow	277.20M	671.10M	-386.40M	582.40M	820.10M	647.80M
Investing Cash Flow	287.30M	263.60M	-154.40M	-266.40M	-112.00M	-169.30M
Financing Cash Flow	-1.18B	-870.10M	331.50M	-237.40M	-747.90M	-250.30M

FMC Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 44.45
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FMC, the sentiment is Positive. The current price of 44.45 is above the 20-day moving average (MA) of 42.20, above the 50-day MA of 39.95, and below the 200-day MA of 47.19, indicating a neutral trend. The MACD of 0.86 indicates Negative momentum. The RSI at 63.95 is Neutral, neither overbought nor oversold. The STOCH value of 67.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FMC.

FMC Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CF	75 Outperform	$14.98B	12.20	26.14%	2.16%	0.66%	25.75%
CTVA	73 Outperform	$52.53B	46.95	4.66%	0.88%	>-0.01%	108.45%
ICL	70 Neutral	$9.03B	23.22	6.70%	2.46%	-3.48%	-18.34%
FMC	69 Neutral	$5.55B	17.06	8.81%	5.22%	1.45%	-70.85%
MOS	69 Neutral	$11.67B	31.74	3.09%	2.39%	-13.37%	-50.63%
SMG	57 Neutral	$3.87B	133.99	4.98%	3.83%	0.75%	―
Sector *	43 Neutral	AU$1.40B	-6.18	-40.62%	4.19%	-4.78%	-42.91%

FMC Corporate Events

FMC Completes $750 Million Subordinated Notes Sale

On May 27, 2025, FMC Corporation completed the sale of $750 million in subordinated notes, which are set to mature in 2055. The notes, governed by a subordinated indenture, offer an 8.450% interest rate until 2030, after which the rate will reset every five years based on the U.S. Treasury Rate plus a spread, but not below 8.450%. The proceeds from this offering will be used to redeem existing senior notes and for general corporate purposes, impacting the company’s debt structure and financial obligations.

The most recent analyst rating on (FMC) stock is a Hold with a $65.00 price target. To see the full list of analyst forecasts on FMC stock, see the FMC Stock Forecast page.

FMC Announces $750M Subordinated Notes Issuance

On May 19, 2025, FMC Corporation entered into an Underwriting Agreement with several underwriters to issue and sell $750 million of 8.450% Fixed-to-Fixed Reset Rate Subordinated Notes due 2055. The transaction is expected to close on May 27, 2025, with net proceeds of approximately $741 million anticipated after expenses. This move is part of FMC’s strategic financial operations, potentially impacting its financial structure and providing capital for future initiatives.

The most recent analyst rating on (FMC) stock is a Hold with a $65.00 price target. To see the full list of analyst forecasts on FMC stock, see the FMC Stock Forecast page.

FMC Announces Leadership Transition with New EVP Appointment

On April 22, 2025, FMC Corporation announced the retirement of Michael F. Reilly, who has been with the company since 2002 and served as Executive Vice President, General Counsel, Chief Compliance Officer, and Secretary since 2019. Reilly will retire fully from FMC on July 1, 2025, after significantly contributing to the company’s transformation into a focused agricultural sciences entity. Sara Velazquez Ponessa has been appointed to succeed Reilly as Executive Vice President, General Counsel, and Corporate Secretary, effective June 1, 2025. Ponessa, who previously worked at FMC and held significant legal roles at Livent Corporation and Arcadium Lithium plc, brings extensive experience and a strong track record to her new position. Her appointment is expected to ensure continuity and strengthen FMC’s legal and compliance functions.